The present disclosure relates to an architecture of energy redistribution that can sustain the increased formation of cofactors like NADH/NADPH and key metabolites like pyruvate that are implicated in the production of isobutanol through biotransformation.
The present disclosure relates to an architecture of energy redistribution that can sustain the increased formation of cofactors like NADH/NADPH and key metabolites like pyruvate that are implicated in the production of isobutanol through biotransformation. Genetically modified microorganisms comprising altered gene...
The present disclosure relates to a pharmaceutical composition and a method to manage Myeloproliferative disorder or any associated condition, particularly, JAK2 (Janus Kinase 2) dominant (including JAK2V617F mutant) Myeloproliferative Disorder (MPD) and associated conditions. The disclosure provides composition com...
[Class : 42] Research And Analysis Of Impact Of Drugs On Various Targets And Its Associated Effects
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.